Amgen Prepares to Showcase Innovation and Access at Upcoming Health Care Conference

Amgen Showcases Commitment to Innovation and Access at Upcoming Health Care Conference

Amgen, a stalwart in the biotechnology sector with over 45 years of expertise, prepares to present at the 46th Annual TD Cowen Health Care Conference on March 2, 2026. Kave Niksefat, Senior Vice President of Global Marketing and Access, along with Justin Claeys, Senior Vice President of Finance, will lead the presentation, which emphasizes Amgen’s ongoing dedication to transforming the lives of millions. This event is a significant opportunity for the company to discuss its pioneering efforts in the biotechnology landscape, particularly highlighting therapies that address critical health challenges such as cancer, heart disease, inflammatory conditions, and obesity-related disorders.

As a key player in the field, Amgen leverages cutting-edge biology and technology to create innovative medications. The company's research and development initiatives focus on impactful medicines that not only demonstrate efficacy but also expand patient access to life-saving treatments. Amgen has established a robust pipeline of therapeutic options, showcasing its commitment to addressing unmet medical needs. The upcoming conference offers a platform for the company to engage with stakeholders and convey its strategic vision for the future, reinforcing its position as a leader in the biotech industry.

Amgen's inclusion in the Dow Jones Industrial Average® and the Nasdaq-100 Index® underscores its stature and financial strength within the sector. Recognized for its workplace culture and innovation by prestigious organizations such as Fast Company and Forbes, Amgen continues to attract top talent and drive advancements in biotechnology. The live webcast of the conference presentation will also be available for replay on Amgen's website for a period of 90 days post-event, facilitating broader outreach and engagement with stakeholders who are interested in the company’s evolving role in healthcare.

In addition to its innovative therapeutic offerings, Amgen emphasizes the importance of accessibility in healthcare. The forthcoming conference presents an opportunity to explore its strategies in global marketing and access, crucial for expanding the reach of its cutting-edge treatments. By leveraging feedback and insights from this prominent event, Amgen aims to enhance its contributions to public health.

To stay informed, Amgen encourages stakeholders and the public to visit their website and follow their social media channels for ongoing updates and developments regarding their work in the biotechnology industry. Media and investor inquiries are also welcomed, demonstrating Amgen’s commitment to transparency and communication in a rapidly evolving healthcare landscape.